![A groundbreaking clinical trial for children with aggressive neuroblastoma - Cancer Research UK - Cancer news A groundbreaking clinical trial for children with aggressive neuroblastoma - Cancer Research UK - Cancer news](https://news.cancerresearchuk.org/wp-content/uploads/2019/09/child_development_hero.jpg)
A groundbreaking clinical trial for children with aggressive neuroblastoma - Cancer Research UK - Cancer news
![TRANSATLANTIC CLINICAL TRIAL FOR CHILDREN WITH NEUROBLASTOMA IS OPEN FOR ENROLLMENT IN THE U.K. - SOON TO OPEN IN THE U.S. AND GERMANY - Band of Parents TRANSATLANTIC CLINICAL TRIAL FOR CHILDREN WITH NEUROBLASTOMA IS OPEN FOR ENROLLMENT IN THE U.K. - SOON TO OPEN IN THE U.S. AND GERMANY - Band of Parents](https://www.bandofparents.org/wp-content/uploads/2018/06/Collaborative-Research-FB.png)
TRANSATLANTIC CLINICAL TRIAL FOR CHILDREN WITH NEUROBLASTOMA IS OPEN FOR ENROLLMENT IN THE U.K. - SOON TO OPEN IN THE U.S. AND GERMANY - Band of Parents
![First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children's Hospital First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children's Hospital](https://www.med.wisc.edu/media/medwiscedu/images/news/afch-building-720.jpg)
First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children's Hospital
![Results of a prospective clinical trial JN‐L‐10 using image‐defined risk factors to inform surgical decisions for children with low‐risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee - Results of a prospective clinical trial JN‐L‐10 using image‐defined risk factors to inform surgical decisions for children with low‐risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee -](https://www.onlinelibrary.wiley.com/cms/asset/d4e7fd2f-d304-4c72-a6ef-8de2ad2fc695/pbc.v66.11.cover.jpg)
Results of a prospective clinical trial JN‐L‐10 using image‐defined risk factors to inform surgical decisions for children with low‐risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee -
CCF on Twitter: "Around 40 children are diagnosed with Neuroblastoma each year. Our funding of the SIOPEN Neuroblastoma Clinical Trials at #ANZCHOG will help identify better therapies and give hope to these
![Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma | Journal of Experimental & Clinical Cancer Research | Full Text Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-020-01582-2/MediaObjects/13046_2020_1582_Fig2_HTML.png)